National Australia Bank Ltd (ASX: NAB) shares have been sold off this Monday after an update. But that means the dividend yield has spiked.

Arrow Greentech Limited delivered robust Q1FY26 results, with consolidated revenue jumping 107% QoQ to ₹89.89 crore. Net profit after tax surged 269% QoQ to ₹27.43 crore, driven by strong top-line growth and improved profitability metrics. Standalone revenue also doubled sequentially to ₹79.16 crore.

Empire Industries posted FY26 net profit of ₹515.48 crore, up 49.6% from the prior year. Revenue from operations increased 8% to ₹7,312.01 crore. Other income rose 24% to ₹184.68 crore, supported by exchange rate variation gains and surplus on sale/redemption of investments. Earnings per share came in at ₹85.91, and the board proposed a total dividend of ₹50 per share, double the previous year.

Dishman Carbogen Amcis reported a consolidated net loss of ₹579 million in Q1FY27, reversing from a net profit of ₹234 million a year earlier. Revenue fell 4.3% year on year to ₹6,776 million. CDMO revenue declined 12.6% to ₹5,344 million after customers asked to push project deliverables worth about CHF 10 million to the second half of the financial year. CDMO’s share of revenue slipped to 79% from 83% in FY26.

Tiger Global reshuffled its tech portfolio in Q2, cutting stakes in Alphabet, Nvidia, Microsoft, Amazon, Meta, Broadcom and TSMC while exiting Netflix. The fund more than doubled its Intel holding and initiated positions in AMD and SpaceX, signalling a shift toward semiconductor exposure and emerging technology opportunities, according to filings.

Australian Clinical Labs Ltd (ASX: ACL) reported full-year revenue of A$735.8 million at the lower end of its guidance, while underlying net profit of A$35.5 million topped consensus expectations of A$31 million. The company’s margin improved year on year to 9.4% and it declared a fully franked dividend of 9.25 cents per share. The shares surged more than 20% intraday before closing up 17% at A$2.75, near the stock’s 12-month high of A$2.97.

Shares of bitcoin development company Strategy fell 3.5% in the afternoon session. MSCI has proposed removing the company from its Global Investable Market Indexes as part of a potential rule change for nonoperating firms with large treasury asset holdings. Investor concerns were also heightened by a recent sale of 1,690 BTC worth roughly $109 million below the company’s average cost basis. Bitcoin slid below $63,000, extending a downtrend since mid July and weighing further on sentiment.

Japan’s Cabinet Office data showed the economy expanded at an annualised 1.1% in the second quarter, undershooting the market’s 2.0% expectation. Private consumption was flat and capital spending fell 1.2% quarter on quarter, stoking worries about weak domestic demand. The Nikkei 225 slipped 0.01% to 68,721.56 in early trading, while the Topix fell 0.48% to 4,177.02. Among heavyweights, Kioxia Holdings rose 5.14% and Trend Micro dropped 8.94%.